Boditech Media
-
PRESS RELEASE
Acquired approval for domestic use of ichroma™ IGRA-TB for Tuberculosis (TB) diagnosis from MFDS
Affordable and Accessible POC test for Latent TB diagnosis
-
PRESS RELEASE
Boditech Med launches two types of diagnostic kits essential for lifestyle diseases prevention
It takes only 5 mins to get a result
-
PRESS RELEASE
Boditech Med has received the export license of AFIAS Golimumab testing kit
It takes 10 mins to get test result with whole blood sample
-
PRESS RELEASE
Boditech Med signed MOU for CRISPR Cas system based diagnosis with nSAGE
It could be a new solution for POC Molecular diagnosis
-
PRESS RELEASE
Boditech Med acquired approval for domestic use of AFIAS COVID-19 antigen diagnostic kit from MFDS
It can detect delta variant and Lambda variant with high accuracy
-
PRESS RELEASE
Boditech Med has received the export license of AFIAS Adalimumab testing kit
It takes only 10 mins to get test result with whole blood sample
-
PRESS RELEASE
Announcing extension of production capacity
Increasing its production capacity two times comparing current capacity
-
PRESS RELEASE
Boditech Med acquires export license for COVID-19 neutralizing antibody diagnostic test
Enabling to diagnose the activity of neutralizing antibodies in 20 mins
-
PRESS RELEASE
Export licenses issued for two types of COVID-19 PCR test kits
Enabling accurate diagnosis by simultaneously detecting three specific genes of COVID-19 with only one sample
-
PRESS RELEASE
Boditech Med acquired Emergency Use Authorization (EUA) from PMDA of Japan for COVID-19 antigen
Recognized its technology in Japan market which is highly sensitive to quality